Covaxin: Bharat Biotech granted permission to start Phase III trials for Covid-19 vaccine

Covaxin 1200x768 0

Bharat Biotech has been granted permission to start the Phase III trials of Covaxin – India’s indigenous Covid-19 vaccine candidate. [REPRESENTATIVE IMAGE] File photo of Covaxin (Picture Courtesy: Twitter @airnewsalerts) The Drug Controller General of India (DGCI) on Thursday allowed Bharat Biotech International Limited to conduct the Phase III trials of its Covid-19 vaccine candidate … Read more